Formulations for c-Met kinase inhibitors

Details for Australian Patent Application No. 2010302419 (hide)

Owner Merck Sharp & Dohme Ltd

Inventors Ward, Robert

Agent Spruson & Ferguson

Pub. Number AU-A-2010302419

PCT Pub. Number WO2011/039527

Priority 61/247,046 30.09.09 US

Filing date 21 September 2010

Wipo publication date 7 April 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/039527 Priority application(s): WO2011/039527

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302420-2-pyridone compounds used as inhibitors of neutrophil elastase

2010302392-Apparatus and method for measuring the flowrate of a multiphase fluid stream